The Interplay among Glucocorticoid Therapy, Platelet-Activating Factor and Endocannabinoid Release Influences the Inflammatory Response to COVID-19

COVID-19 is associated with a dysregulated immune response. Currently, several medicines are licensed for the treatment of this disease. Due to their significant role in inhibiting pro-inflammatory cytokines and lipid mediators, glucocorticoids (GCs) have attracted a great deal of attention. Similar...

Descripción completa

Detalles Bibliográficos
Autores principales: de Carvalho, Jonatan C. S., da Silva-Neto, Pedro V., Toro, Diana M., Fuzo, Carlos A., Nardini, Viviani, Pimentel, Vinícius E., Pérez, Malena M., Fraga-Silva, Thais F. C., Oliveira, Camilla N. S., Degiovani, Augusto M., Ostini, Fátima M., Feitosa, Marley R., Parra, Rogerio S., da Rocha, José J. R., Feres, Omar, Vilar, Fernando C., Gaspar, Gilberto G., Santos, Isabel K. F. M., Fernandes, Ana P. M., Maruyama, Sandra R., Russo, Elisa M. S., Bonato, Vânia L. D., Cardoso, Cristina R. B., Dias-Baruffi, Marcelo, Faccioli, Lúcia H., Sorgi, Carlos A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959303/
https://www.ncbi.nlm.nih.gov/pubmed/36851787
http://dx.doi.org/10.3390/v15020573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959303/
https://www.ncbi.nlm.nih.gov/pubmed/36851787
http://dx.doi.org/10.3390/v15020573

Ejemplares similares